Invention Grant
- Patent Title: Compositions and methods
-
Application No.: US16090142Application Date: 2017-03-28
-
Publication No.: US10682354B2Publication Date: 2020-06-16
- Inventor: Lawrence P. Wennogle
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- International Application: PCT/US2017/024575 WO 20170328
- International Announcement: WO2017/172795 WO 20171005
- Main IPC: A61K31/498
- IPC: A61K31/498 ; A61K31/517 ; A61K31/519 ; A61K31/4985
Abstract:
The invention provides methods for the prophylaxis or treatment of one or more disorders associated with dementia comprising administering to a patient in need thereof, a therapeutically effective amount of (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor, and pharmaceutical compositions comprising (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor.
Public/Granted literature
- US20200022981A9 NOVEL COMPOSITIONS AND METHODS Public/Granted day:2020-01-23
Information query
IPC分类:
